PPP1R14B and cancer: Pan-cancer analysis revealed that increased PPP1R14B expression correlated with poor prognosis and increased immune infiltration levels in myeloid-derived suppressor cells (MDSCs), and PPP1R14B could be used as a prognostic biomarker for pan-cancer (122).